Mills AR, de Souza A, Pham T et al. · Experimental physiology · PMID 42321010
From the original abstract
“These results indicate that MOTS-c modulates both systemic and cardiac inflammation in T2DM, providing a novel therapeutic approach for reducing cardiovascular risk in diabetic patients.”
From the closing sentence of the indexed abstract. This is a short quotation from the authors, not a full study appraisal.
Read the full abstract & conclusionCheck the methods for the exact molecule, preparation, and research model. Measurements of a naturally occurring peptide differ from testing its administration. Cell and animal findings need separate evaluation in people.
A brief excerpt cannot capture the complete methods, results, adverse events, or limitations. Check the full abstract and original paper before interpreting the finding.
Educational research information. A publication does not verify the identity, quality, or safety of products sold here.
Back to MOTS-c studies